Bio-Techne logo

Bio-Techne

TECH | NASDAQ
Chart Builder DCF Calculator
$72.79
-$0.01 (-0.01%)
At close: Nov 16, 2026, 4:00 PM ET
$72.64
-$0.15 (-0.21%)
After-hours: Nov 16, 2026, 7:32 PM ET
-0.01%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
46.4
Fundamentals Average
Market Sentiment Bullish
Moat Narrow
Sector Rank #361/1021 (Top 35%)

Key Statistics

Market Data

Market Cap $11.43B
1D Range
72.71 72.90
52W Range
43.30 72.90

Valuation (TTM)

PE 66.17
PB 5.28
EV/EBITDA 37.31

Valuation (NTM)

Forward PE 35.51
Forward PEG 9.81
Price Target $73.00
Loading financial charts...

Profile

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worl...

Sector Healthcare
Industry Biotechnology
Employees 3,000
IPO Date Feb 9, 1989
Fiscal Year July - June

Latest News

CMB.TECH ANNOUNCES Q3 2026 RESULTS ON 26/11/2026

4 days ago · globenewswire.com

CMB.TECH ANNOUNCES Q3 2026 RESULTS ON 26/11/2026
TECH Q1 Earnings & Revenues Beat, Merck KGaA Merger Deal Advances

8 days ago · zacks.com

TECH Q1 Earnings & Revenues Beat, Merck KGaA Merger Deal Advances
Bio-Techne's Q1 Earnings on Deck: What's in Store for the Stock?

15 days ago · zacks.com

Bio-Techne's Q1 Earnings on Deck: What's in Store for the Stock?
Press release: CMB.TECH fleet update

1 month ago · globenewswire.com

Press release: CMB.TECH fleet update
CMB.TECH SPECIAL GENERAL MEETING RESULTS

1 month ago · globenewswire.com

CMB.TECH SPECIAL GENERAL MEETING RESULTS
INTURAI PROVIDES DEFENCE TECH COMPETITION RESULTS AND COMPANY UPDATE

2 months ago · prnewswire.com

INTURAI PROVIDES DEFENCE TECH COMPETITION RESULTS AND COMPANY UPDATE
Zhibao Technology Signs Definitive Agreement to Acquire NEXSYS TECH for Planned AI Computing Infrastructure Business

2 months ago · newsfilecorp.com

Zhibao Technology Signs Definitive Agreement to Acquire NEXSYS TECH for Planned AI Computing Infrastructure Business
Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany

2 months ago · prnewswire.com

Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany

2 months ago · prnewswire.com

Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration
Why Is Techne (TECH) Down 0.1% Since Last Earnings Report?

2 months ago · zacks.com

Why Is Techne (TECH) Down 0.1% Since Last Earnings Report?

Earnings

Latest Earnings
Nov 6, 2026
EPS
$0.44
Beat 0.00%
REV
$299.71M
Beat +2.43%
Next Earnings
Feb 3, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
12
Consensus
Hold
Price Target
$73.00
Upside
+0.29%
Buy (2)
Hold (10)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.